Terms ending in 2041
Every in-force patent on Cybin UK Ltd.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,471,417 | Deuterated N,n-Dimethyltryptamine Compounds In force · High confidence | Cybin UK Ltd. | In force | High confidence | |
| US 11,773,062 | Deuterated Compounds In force · High confidence | Cybin UK Ltd. | In force | High confidence | |
| US 12,042,564 | Therapeutic Solid Dosage Forms In force · High confidence | Cybin UK Ltd. | In force | High confidence | |
| US 12,251,371 | Deuterated or Partially Deuterated N,n-Dimethyltryptamine Compounds In force · High confidence | Cybin UK Ltd. | In force | High confidence | |
| US 12,521,370 | Inhalable Formulations In force · Medium confidence | Cybin UK Ltd. | In force | Medium confidence | |
| US 11,697,638 | 5-Methoxy-N,N-DIMETHYLTRYPTAMINE Crystalline Forms In force · High confidence | Cybin UK Ltd. | In force | High confidence | |
| US 11,660,289 | Deuterated or Partially Deuterated N,n-Dimethyltryptamine Compounds In force · Medium confidence | Cybin UK Ltd. | In force | Medium confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.